Rifampin phosphotransferase is an unusual antibiotic resistance kinase

Rifampin (RIF) phosphotransferase (RPH) confers antibiotic resistance by conversion of RIF and ATP, to inactive phospho-RIF, AMP and P i . Here we present the crystal structure of RPH from Listeria monocytogenes (RPH- Lm ), which reveals that the enzyme is comprised of three domains: two substrate-b...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 7; no. 1; pp. 11343 - 12
Main Authors Stogios, Peter J., Cox, Georgina, Spanogiannopoulos, Peter, Pillon, Monica C., Waglechner, Nicholas, Skarina, Tatiana, Koteva, Kalinka, Guarné, Alba, Savchenko, Alexei, Wright, Gerard D.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 22.04.2016
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rifampin (RIF) phosphotransferase (RPH) confers antibiotic resistance by conversion of RIF and ATP, to inactive phospho-RIF, AMP and P i . Here we present the crystal structure of RPH from Listeria monocytogenes (RPH- Lm ), which reveals that the enzyme is comprised of three domains: two substrate-binding domains (ATP-grasp and RIF-binding domains); and a smaller phosphate-carrying His swivel domain. Using solution small-angle X-ray scattering and mutagenesis, we reveal a mechanism where the swivel domain transits between the spatially distinct substrate-binding sites during catalysis. RPHs are previously uncharacterized dikinases that are widespread in environmental and pathogenic bacteria. These enzymes are members of a large unexplored group of bacterial enzymes with substrate affinities that have yet to be fully explored. Such an enzymatically complex mechanism of antibiotic resistance augments the spectrum of strategies used by bacteria to evade antimicrobial compounds. Antibiotic resistance is a major clinical problem that threatens to undermine our ability to control infectious diseases. Here the authors present detailed structural analysis of Rifampin phosphotransferase from Listeria monocytogenes , yielding insight on how this class of enzyme inactivates its target antibiotics.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
National Institutes of Health (NIH)
These authors contributed equally to this work.
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms11343